Found: 5
Select item for more details and to access through your institution.
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer: The results of the GERCOR OPTIMOX 1 study.
- Published in:
- Health & Quality of Life Outcomes, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7525-12-69
- By:
- Publication type:
- Article
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 496, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article